CSIMarket
 


Respirerx Pharmaceuticals Inc   (RSPI)
Other Ticker:  
 

Respirerx Pharmaceuticals Inc 's Quick Ratio

RSPI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2023, Quick Ratio deteriorated to 0 a new company low.

Within Major Pharmaceutical Preparations industry 545 other companies have achieved higher Quick Ratio than Respirerx Pharmaceuticals Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 4571 to 4986.

Explain Quick Ratio?
How much Cash & cash equivalents RSPI´s has?
What are RSPI´s Current Liabilities?


RSPI Quick Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Change 11.25 % 14.76 % 18.21 % 22.68 % 22.5 %
Y / Y Cash & cash equivalent Change 34761.9 % -45.24 % -93.71 % -89.21 % -99.93 %
Quick Ratio MRQ 0 0 0 0 0
RSPI's Total Ranking # 4986 # 4571 # 5449 # 5082 # 5140
Seq. Current Liabilities Change -0.63 % 4.76 % 2.55 % 4.21 % 2.5 %
Seq. Cash & cash equivalent Change 5205.07 % 56.82 % 46.67 % 185.71 % -91.67 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 546
Healthcare Sector # 1114
Overall Market # 4986


Quick Ratio Statistics
High Average Low
0.08 0.01 0
(Jun 30 2016)   (Jun 30 2019)




Financial Statements
Respirerx Pharmaceuticals Inc 's Current Liabilities $ 12 Millions Visit RSPI's Balance sheet
Respirerx Pharmaceuticals Inc 's Cash & cash equivalent $ 0 Millions Visit RSPI's Balance sheet
Source of RSPI's Sales Visit RSPI's Sales by Geography


Cumulative Respirerx Pharmaceuticals Inc 's Quick Ratio

RSPI's Quick Ratio for the trailling 12 Months

RSPI Quick Ratio

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities TTM Growth 11.25 % 14.76 % 18.21 % 22.68 % 22.5 %
Y / Y Cash & cash equivalent TTM Growth 34761.9 % -45.24 % -93.71 % -89.21 % -99.93 %
Quick Ratio TTM 0 0 0 0 0
Total Ranking TTM # 4194 # 4268 # 4488 # 4261 # 5199
Seq. Current Liabilities TTM Growth -0.63 % 4.76 % 2.55 % 4.21 % 2.5 %
Seq. Cash & cash equivalent TTM Growth 5205.07 % 56.82 % 46.67 % 185.71 % -91.67 %


On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the II Quarter 2023 to $12.21 millions, cumulative Quick Ratio